Congenital Hyperinsulinism Market to Expand at a CAGR of 12% During the Forecast Period (2026-2036) as Rising Disease Recognition and Novel Therapies Fuel Market Growth | DelveInsight

Positive

AI Analysis

Summary

Market analysis report projects the congenital hyperinsulinism market will expand at a 12% CAGR from 2026-2036, driven by increased disease recognition, improved screening, and advances in genetic and molecular diagnostics.

Importance:2/10

Sentiment:

0.50

market analysiscongenital hyperinsulinismdisease awarenessneonatal screeninggenetic diagnostics

Related Companies

$MOLN

Read the original article

Published by PR Newswire Pharma on August 26, 2026 2:31 PM

Read Original